M

Medanta

www.medanta.org link_icon

Company Research Report: Medanta (Global Health Limited)



Company Overview



  • Name: Medanta (Global Health Limited)

  • Mission: Deliver world-class healthcare by fostering collaboration and multispecialty care integration.

  • Founded: The specific founding date and founders' names are not detailed in the provided information.

  • Key People:

  • Dr. Naresh Trehan, Chairman and Managing Director

  • Dr. Anshul Gupta, Head of the Department of Hematology & BMT at Medanta, Lucknow

  • Dr. Praveen Chandra, Chairman of Interventional Cardiology

  • Headquarters: Gurugram, India

  • Number of Employees: Approximately 1,400 doctors are part of the Medanta network, led by experienced department heads.

  • Revenue: No information is available

  • Known For: High-quality care through a doctor-led model, offering superspecialised care across multiple disciplines, including cardiac sciences, neurosciences, oncology, and robotics, among others.


Products and Services



  • Specialties:

  • Cardiac Care

  • Cancer Care

  • Neurosciences

  • Gastrosciences

  • Orthopaedics

  • Renal Care


  • Products and Key Features:

  • Advanced Medical Technology:

  • CyberKnife VSI Robotic Radiosurgery System

  • Da Vinci Si Robotic Surgery

  • Varian EDGE and Cyberknife for precision radiation oncology

  • Brain Suite (MRI inside an OT)

  • Artis-Zeego Endovascular Surgical Cath Lab

  • Innovative Healthcare Processes:

  • Integration of multispecialty care

  • State-of-the-art diagnostic equipment including PET Scan and 256 Slice CT

  • Telehealth services and wider accessibility through digital platforms


Recent Developments



  • Recent Developments:

  • Medanta Gurugram has been ranked as one of the World's Best Hospitals for the fifth time by Newsweek (April 2024).

  • Launch of a pediatric epilepsy care clinic in Lucknow (September 2024).

  • Medanta Lucknow achieved a milestone of 52 successful Bone Marrow Transplants and Cellular Therapy Cases (October 2024).

  • Medanta was the first in North India to be recognized as an “Active Emerging Lung Transplant Centre” (August 2024).


  • New Products and Initiatives:

  • Introduction of the CAR-T cell therapy for refractory blood cancers in Lucknow.

  • Launch of the "Heart 2 Heart" monthly talk show focusing on cardiac care, starting February 2024.


  • Partnerships and Innovations:

  • Medanta has emerged as a leader in using AI-enabled Penumbra Lightning technology for the successful treatment of pulmonary embolism.

  • Collaborations to enhance public health awareness, such as tuberculosis care campaigns, liver-related disease days, and organ donation and transplant awareness.


Medanta's constant push for medical innovation, along with comprehensive care and advanced medical infrastructure, positions it as a forerunner in providing reliable and specialized healthcare services across its hospital network.